Precision Neuroscience raises $250m at a $1bn valuation, NYT reports

Precision Neuroscience has raised $250m in a Series D round for its brain-computer interface, the New York company announced on Thursday. Bill Ackman’s Pershing Square, the Ackman Oxman Institute and an unnamed life sciences fund led the round. The round values Precision at just over $1bn, The New York Times reported.